Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00713700 · ClinicalTrials.gov registry record · NA
AMPLATZER Duct Occluder II Clinical Study
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
NCT00713700: Completed NA study, sponsored by Abbott Medical Devices.
NCT00713700 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 192 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00713700, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
Study Summary
The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.
Primary Outcome
The primary safety endpoint is the rate of device and/or procedure related SAEs reported in subjects whom device placement is attempted from the procedure through 180 days post procedure SAEs are defined as: Adverse events resulting in the following; death, life-threatening adverse event, inpatient hospitalization or prolongation of existing hospital stay, persistent or significant disability/incapacity or medically significant event.
Interventions
- DEVICE AMPLATZER Duct Occluder II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2008-08 |
| Est. Completion | 2016-10-05 |
| Phase | NA |
What the finished NCT00713700 record still lists
NCT00713700 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which AMPLATZER Duct Occluder II is the first listed.
NCT00713700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00713700 about?
NCT00713700 is a clinical study titled "AMPLATZER Duct Occluder II Clinical Study". The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.
What is the current status of trial NCT00713700?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2008-08. Estimated completion is 2016-10-05.
What interventions are being tested in trial NCT00713700?
The interventions under investigation include: AMPLATZER Duct Occluder II (DEVICE).
Who is sponsoring clinical trial NCT00713700?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00713700's enrollment target sits among peer trials
192 570th of 2000 higher than 1,427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia